Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 2/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 2/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
| ▸ | MMP9 | P14780 | 2/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27804436 | 0.90 | GSK3B (0.47) | PTPN1PTGS2GSK3BTP53 | |
| SCHEMBL9360541 | 0.87 | PTGS2 (0.49) | PTPN1PTGS2GSK3B | |
| SCHEMBL10886758 | 0.83 | PTPN1 (0.52) | PTPN1LTA4HMMP2MMP9SOAT1 | |
| SCHEMBL3671032 | 0.75 | PTGS2 (0.44) | PTPN1PTGS2GSK3BMMP2MMP9 | |
| SCHEMBL11331340 | 0.75 | PTPN1 (0.58) | PTPN1LTA4HSOAT1CNR2TP53 | |
| SCHEMBL211025 | 0.74 | PDE4B (0.59) | PTGS2GSK3BTP53CYP3A4LMNA | |
| SCHEMBL1817005 | 0.74 | PTGS2 (0.46) | PTPN1PTGS2GSK3BMMP2MMP9 | |
| SCHEMBL27825209 | 0.73 | GSK3B (0.42) | PTGS2GSK3B | |
| SCHEMBL9436192 | 0.73 | GSK3B (0.42) | PTGS2GSK3B | |
| SCHEMBL3719735 | 0.73 | PTGS2 (0.51) | PTGS2GSK3BMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130299747-A1 | CURATIVES FOR EPOXY COMPOSITIONSERS | DESIGNER MOLECULES, INC. | 2013-11-14 | — | — | US | disclosed |
| US-20130199724-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8431655-B2 | Curatives for epoxy compositions | DESIGNER MOLECULES, INC. (US) | 2013-04-30 | — | — | US | disclosed |
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| WO-2008124797-A1 | CURATIVES FOR EPOXY COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| CN-100412161-C | Liquid crystal aligning agent and liquid crystal display element | JSR CORP (JP) | 2008-08-20 | — | — | CN | disclosed |
| CN-100344731-C | Liquid crystal aligning agent and liquid crystal display element | JSR CORP (JP) | 2007-10-24 | — | — | CN | disclosed |
| CN-1721502-A | Liquid crystal aligning agent and liquid crystal display element | JSR CORP (JP) | 2006-01-18 | — | — | CN | disclosed |
| CN-1408817-A | Liquid crystal aligning agent and liquid crystal display element | JSR CORP (JP) | 2003-04-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249276-A1 | CURATIVES FOR EPOXY COMPOSITIONS | ALOX5, LTC4S, ALOX15B | PTPN1 4703/4885PTGS2 56/4885LTA4H 24/4885 |
| US-20100113643-A1 | CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS | ALOX5, LTC4S, ALOX15B | PTPN1 4776/4885PTGS2 86/4885LTA4H 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.